AngioDynamics Inc (ANGO)
AngioDynamics, Inc. is a medical technology company that develops, manufactures, and markets medical, surgical, and diagnostic devices used in peripheral vascular disease, oncology, and surgical procedures. Its portfolio includes the Auryon atherectomy system, thrombus management products such as the AlphaVac mechanical thrombectomy system and thrombolytic catheters, and the AngioVac venous drainage cannula and extracorporeal circuit. The company also offers the NanoKnife IRE Ablation System, peripheral diagnostic and interventional products, abscession drainage catheters, micro-access kits, the VenaCure EVLT system, and the Solero Microwave Tissue Ablation System. AngioDynamics sells its products in the United States and international markets. The company was founded in 1988 and is headquartered in Latham, New York.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-ANGO
|
$10.96
|
-20.9% Downside
|
Overvalued
|
$20
|
44.3% Upside
|
Undervalued
|
Good
|
—
|
—
|
—
|
0.0%
|
October 1, 2026
|
-15.6x
|
3.4x
|
1.8x
|
566.7 M
|
532 M
|
1.9%
|
77.9%
|
2.1
|
—
|
-1.4%
|
